AssetMark Inc’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.1K | Hold |
1,860
| – | – | ﹤0.01% | 1740 |
|
|
2025
Q1 | $29.1K | Hold |
1,860
| – | – | ﹤0.01% | 1599 |
|
|
2024
Q4 | $25.9K | Hold |
1,860
| – | – | ﹤0.01% | 1594 |
|
|
2024
Q3 | $17.3K | Hold |
1,860
| – | – | ﹤0.01% | 1526 |
|
|
2024
Q2 | $17.3K | Hold |
1,860
| – | – | ﹤0.01% | 1409 |
|
|
2024
Q1 | $18.4K | Hold |
1,860
| – | – | ﹤0.01% | 1294 |
|
|
2023
Q4 | $6.01K | Hold |
1,860
| – | – | ﹤0.01% | 1434 |
|
|
2023
Q3 | $9.88K | Hold |
1,860
| – | – | ﹤0.01% | 1335 |
|
|
2023
Q2 | $17.7K | Buy |
1,860
+255
| +16% | +$2.43K | ﹤0.01% | 1227 |
|
|
2023
Q1 | $17.7K | Buy |
1,605
+250
| +18% | +$2.75K | ﹤0.01% | 1205 |
|
|
2022
Q4 | $20.1K | Buy |
1,355
+440
| +48% | +$6.51K | ﹤0.01% | 1203 |
|
|
2022
Q3 | $17K | Buy |
915
+375
| +69% | +$6.97K | ﹤0.01% | 1152 |
|
|
2022
Q2 | $12K | Buy |
+540
| New | +$12K | ﹤0.01% | 1197 |
|